CKD (6407) Q2 2026 earnings summary

Executive summary

• Net sales for the six months ended September 30, 2025, were ¥72,648 million, down 4.1% year-over-year, with operating profit at ¥7,867 million, down 14.2%, and profit attributable to owners of parent at ¥5,376 million, down 15.2%.

• The global economy remained uncertain due to geopolitical risks and policy changes, with semiconductor demand driven by AI and data centers, but a full recovery expected next year.

• Comprehensive income rose sharply to ¥7,482 million, up 83.6% year-over-year.

Financial highlights

• Gross profit for the period was ¥21,189 million, with a gross margin of 29.2%.

• Basic earnings per share were ¥80.48, compared to ¥94.96 in the prior year period.

• Cash and cash equivalents at period end were ¥36,260 million, up ¥1,915 million from March 31, 2025.

• Net assets increased to ¥141,238 million, with an equity-to-asset ratio of 66.4%.

Outlook and guidance

• Full-year net sales forecast revised downward to ¥151,000 million (down 3.2% from previous forecast), with operating profit expected at ¥16,600 million (down 12.6%) and profit attributable to owners of parent at ¥11,200 million (down 14.5%).

• Demand recovery for semiconductor-related components is slower than anticipated; a full recovery is now expected in fiscal year 2026 or later.

• Dividend forecast for the year ending March 31, 2026, is ¥67.00 per share, revised from previous guidance.